Hence, combining two ultrasound and AFP methods can considerably increase the sensitivity of HCC detection in clinical practice; however, these methods are also insufficient (Tzartzeva et al., 2018[157]). The gene discussed is AFP; the disease is hepatocellular carcinoma.